Cargando…
Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory
BACKGROUND: We evaluated the performance of a cell‐free DNA (cfDNA) prenatal screening assay for trisomies 21, 18, and 13, and sex chromosome aneuploidies (SCAs) among a population of pregnant women that included both those at average and high risk. METHODS: Specimen collection, cfDNA extraction, ma...
Autores principales: | Guy, Carrie, Haji‐Sheikhi, Farnoosh, Rowland, Charles M., Anderson, Ben, Owen, Renius, Lacbawan, Felicitas L., Alagia, Damian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418367/ https://www.ncbi.nlm.nih.gov/pubmed/30706702 http://dx.doi.org/10.1002/mgg3.545 |
Ejemplares similares
-
Prenatal diagnosis of fetal aneuploidies: post-genomic developments
por: Hahn, Sinuhe, et al.
Publicado: (2010) -
Prenatal diagnosis of common fetal aneuploidies: Scenario in India
por: Baburao, V., et al.
Publicado: (2013) -
Economic evaluation of prenatal screening for fetal aneuploidies in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023) -
Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples
por: Futch, Tracy, et al.
Publicado: (2013) -
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening
por: Choe, Seung-Ah, et al.
Publicado: (2021)